{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:44:23Z","timestamp":1790844263683,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.leukres.2016.11.014","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T19:19:15Z","timestamp":1480447155000},"page":"65-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"53","author":[{"given":"Christos K.","family":"Kontos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios G.","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios A.","family":"Diamantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Scorilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimia","family":"Bazani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diamantina","family":"Vasilatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Gkontopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Glezou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Stavroulaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dimitriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Pappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2016.11.014_bib0005","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2016.11.014_bib0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/1042819021000035756","article-title":"Biological and clinical heterogeneity of B-cell chronic lymphocytic leukemia","volume":"44","author":"D'Arena","year":"2003","journal-title":"Leuk. Lymphoma"},{"issue":"Suppl. 6","key":"10.1016\/j.leukres.2016.11.014_bib0015","doi-asserted-by":"crossref","first-page":"vi50","DOI":"10.1093\/annonc\/mdr377","article-title":"Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"22","author":"Eichhorst","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2016.11.014_bib0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.014_bib0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2016.11.014_bib0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.blre.2008.03.003","article-title":"New prognostic markers in chronic lymphocytic leukemia","volume":"22","author":"Moreno","year":"2008","journal-title":"Blood Rev."},{"key":"10.1016\/j.leukres.2016.11.014_bib0035","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia","volume":"348","author":"Crespo","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2016.11.014_bib0040","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","article-title":"CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease","volume":"99","author":"Hamblin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.014_bib0045","first-page":"115","article-title":"Chronic lymphocytic leukemia: prognostic factors and impact on treatment","volume":"11","author":"Parker","year":"2011","journal-title":"Discov. Med."},{"key":"10.1016\/j.leukres.2016.11.014_bib0050","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1038\/emboj.2012.125","article-title":"The updated biology of hypoxia-inducible factor","volume":"31","author":"Greer","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.leukres.2016.11.014_bib0055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.leukres.2016.11.014_bib0060","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1182\/blood-2008-10-185686","article-title":"Aberrant regulation of pVHL levels by microRNA promotes the HIF\/VEGF axis in CLL B cells","volume":"113","author":"Ghosh","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.014_bib0065","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood-2015-07-657056","article-title":"HIF-1alpha regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment","volume":"127","author":"Valsecchi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.014_bib0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1746-1596-3-16","article-title":"Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence","volume":"3","author":"Frater","year":"2008","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.leukres.2016.11.014_bib0075","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.clinbiochem.2015.04.007","article-title":"KLKB1 mRNA overexpression: a novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia","volume":"48","author":"Adamopoulos","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.leukres.2016.11.014_bib0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.leukres.2016.11.014_bib0085","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.leukres.2016.11.014_bib0090","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2016.11.014_bib0095","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1016\/j.febslet.2012.07.016","article-title":"Regulation of CLL survival by hypoxia-inducible factor and its target genes","volume":"586","author":"Shachar","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.leukres.2016.11.014_bib0100","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.3109\/10428194.2012.696637","article-title":"Hypoxia-inducible factor-1alpha expression indicates poor prognosis in myelodysplastic syndromes","volume":"53","author":"Tong","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2016.11.014_bib0105","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/sj.leu.2401825","article-title":"Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia","volume":"14","author":"Kini","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2016.11.014_bib0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/leu.2015.187","article-title":"Metabolic plasticity in CLL: adaptation to the hypoxic niche","volume":"30","author":"Koczula","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2016.11.014_bib0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia\u2013a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.leukres.2016.11.014_bib0120","first-page":"2911","article-title":"Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer","volume":"61","author":"Aebersold","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2016.11.014_bib0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/1097-0142(20010701)92:1<165::AID-CNCR1305>3.0.CO;2-F","article-title":"Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis","volume":"92","author":"Birner","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2016.11.014_bib0130","first-page":"1313","article-title":"Expression of hypoxia-inducible factor 1-alpha and vascular endothelial growth factor-C in locally advanced breast cancer patients","volume":"66","author":"Brito","year":"2011","journal-title":"Clinics (Sao Paulo, Brazil)"},{"key":"10.1016\/j.leukres.2016.11.014_bib0135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.oraloncology.2010.11.014","article-title":"Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma","volume":"47","author":"Liang","year":"2011","journal-title":"Oral Oncol."},{"key":"10.1016\/j.leukres.2016.11.014_bib0140","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.lungcan.2010.08.005","article-title":"Prognostic implications of hypoxia-inducible factor-1alpha in epidermal growth factor receptor-negative non-small cell lung cancer","volume":"72","author":"Park","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.leukres.2016.11.014_bib0145","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.leukres.2010.10.020","article-title":"Hypoxia-inducible factor-1alpha protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia","volume":"35","author":"Deeb","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2016.11.014_bib0150","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2403332","article-title":"Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF","volume":"18","author":"Wellmann","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2016.11.014_bib0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00277-010-1070-6","article-title":"Hypoxia-inducible factors in mantle cell lymphoma: implication for an activated mTORC1\u2192HIF-1alpha pathway","volume":"90","author":"Argyriou","year":"2011","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2016.11.014_bib0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2559.2002.01357.x","article-title":"Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma","volume":"40","author":"Stewart","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.leukres.2016.11.014_bib0165","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1172\/JCI23409","article-title":"In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells","volume":"115","author":"Messmer","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.leukres.2016.11.014_bib0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semcancer.2013.06.010","article-title":"How the microenvironment wires the natural history of chronic lymphocytic leukemia","volume":"24","author":"Caligaris-Cappio","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.leukres.2016.11.014_bib0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2013.08.011","article-title":"The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies","volume":"24","author":"Burger","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.leukres.2016.11.014_bib0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-4614-8051-8_9","article-title":"Molecular biomarkers in chronic lymphocytic leukemia","volume":"792","author":"Malek","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.leukres.2016.11.014_bib0185","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.014_bib0190","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2008-04-154070","article-title":"Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up","volume":"112","author":"Zenz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.014_bib0195","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.014_bib0200","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1182\/blood-2005-12-4986","article-title":"Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia","volume":"108","author":"Del Principe","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.014_bib0205","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1182\/blood-2011-09-379966","article-title":"Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia","volume":"119","author":"Rossi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.014_bib0210","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1182\/blood-2013-02-427641","article-title":"SF3B1 mutations in chronic lymphocytic leukemia","volume":"121","author":"Wan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.014_bib0215","doi-asserted-by":"crossref","first-page":"435983","DOI":"10.1155\/2014\/435983","article-title":"Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go","volume":"2014","author":"Puiggros","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.leukres.2016.11.014_bib0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cancergencyto.2006.07.006","article-title":"Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia","volume":"171","author":"Ripolles","year":"2006","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.leukres.2016.11.014_bib0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02685899","article-title":"Recent advances in the diagnosis and therapy of Richter's syndrome","volume":"24","author":"Swords","year":"2007","journal-title":"Med. Oncol."},{"key":"10.1016\/j.leukres.2016.11.014_bib0230","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1007\/s13277-015-3083-1","article-title":"SOX11 expression in chronic lymphocytic leukemia correlates with adverse prognostic markers","volume":"36","author":"Roisman","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.leukres.2016.11.014_bib0235","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ygyno.2014.10.018","article-title":"DNA methylation as a biomarker for the detection of hidden carcinoma in endometrial atypical hyperplasia","volume":"135","author":"Lai","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.leukres.2016.11.014_bib0240","doi-asserted-by":"crossref","first-page":"159632","DOI":"10.1155\/2014\/159632","article-title":"Serum soluble TACI, a BLyS receptor, is a powerful prognostic marker of outcome in chronic lymphocytic leukemia","volume":"2014","author":"Kyrtsonis","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.leukres.2016.11.014_bib0245","doi-asserted-by":"crossref","first-page":"e83250","DOI":"10.1371\/journal.pone.0083250","article-title":"BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis","volume":"8","author":"Pelekanou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2016.11.014_bib0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000353757","article-title":"HLA-G expression as a prognostic indicator in B-cell chronic lymphocytic leukemia","volume":"132","author":"Attia","year":"2014","journal-title":"Acta Haematol."},{"key":"10.1016\/j.leukres.2016.11.014_bib0255","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4161\/15592294.2014.969628","article-title":"Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients","volume":"9","author":"Van Damme","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.leukres.2016.11.014_bib0260","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1515\/cclm-2015-0456","article-title":"mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients","volume":"54","author":"Kontos","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.leukres.2016.11.014_bib0265","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1634\/theoncologist.2010-0349","article-title":"The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker","volume":"16","author":"Papageorgiou","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.leukres.2016.11.014_bib0270","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2119\/molmed.2014.00214","article-title":"Opposite prognostic significance of cellular and serum circulating microRNA-150 in chronic lymphocytic leukemia patients","volume":"21","author":"Stamatopoulos","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.leukres.2016.11.014_bib0275","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/bjh.13077","article-title":"Accumulation of adverse prognostic markers worsens prognosis in chronic lymphocytic leukaemia","volume":"168","author":"Truger","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2016.11.014_bib0280","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood-2014-02-556399","article-title":"Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia","volume":"124","author":"Pflug","year":"2014","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616302600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616302600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T15:58:04Z","timestamp":1601222284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212616302600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":56,"alternative-id":["S0145212616302600"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2016.11.014","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2016.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}